Symphony Asset Management’s Novartis NVS Stock Holding History

Symphony Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,238	Closed	-$249K	–	415
2015 Q4	$249K	Sell	3,238 -1,562	-33%	-$124K	0.03%	393
2015 Q3	$395K	Sell	4,800 -10,176	-68%	-$906K	0.05%	349
2015 Q2	$1.32M	Sell	14,976 -1,222	-8%	-$112K	0.16%	150
2015 Q1	$1.43M	Buy	16,198 +13,585	+520%	+$1.2M	0.17%	132
2014 Q4	$217K	Buy	2,613 +224	+9%	+$18.6K	0.03%	378
2014 Q3	$202K	Buy	+2,389	New	+$193K	0.02%	393
2014 Q1	–	Sell	-8,348	Closed	-$601K	–	456
2013 Q4	$601K	Buy	+8,348	New	+$580K	0.04%	260

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Symphony Asset Management's NVS Position: Q1 2016 in Review

Symphony Asset Management sold out of Novartis (NVS) in Q1 2016, closing a stake of 3,238 shares — an estimated $249K sold.

Symphony Asset Management first reported a position in NVS in Q4 2013 and held it in 7 quarters. The position peaked at $1.43M in Q1 2015. 875 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

Symphony Asset Management reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
Symphony Asset Management sold 3,238 Novartis shares in Q1 2016, an estimated $249K.
Symphony Asset Management first reported a position in Novartis in Q4 2013 and held it in 7 quarters.
Symphony Asset Management's Novartis position peaked at $1.43M in Q1 2015.
875 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Symphony Asset Management's 13F filing for Q1 2016, filed 13 May 2016.